Anu R I: Published!!! One of our largest studies on MUTYH in cancer.

Anu R I, a precision oncology specialist and a consultant of clinical biochemistry at MVR CCRI, India, recently tweeted:

“Published!!! One of our largest studies on MUTYH in cancer.
2,29,120 patients,
MUTYH alteration is associated with increased TMB, elevated KRAS G12C mutation, higher SBS18 and SBS36 mutations,
Higher neoantigen load,
Potential immunotherapy benefits.”

For the article click here.
Source: Anu R I/Twitter